U-Blot® Research Grade LuveltamabCat. No. WA3124$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LuveltamabCat. No. WA3124
U-Blot® Research Grade LuvagrobartCat. No. WA3123
U-Blot® Research Grade LutikizumabCat. No. WA3122
U-Blot® Research Grade LusvertikimabCat. No. WA3121
U-Blot® Research Grade LuspaterceptCat. No. WA3120
U-Blot® Research Grade LupartumabCat. No. WA3119
U-Blot® Research Grade LunsekimigCat. No. WA3118
U-Blot® Research Grade lunlekitugCat. No. WA3117
U-Blot® Research Grade LumrotatugCat. No. WA3116
U-Blot® Research Grade LumretuzumabCat. No. WA3115
U-Blot® Research Grade lumivatamigCat. No. WA3114
U-Blot® Research Grade LumistobartCat. No. WA3113